866-997-4948(US-Canada Toll Free)

Vermillion, Inc. (VRML) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Jun 2012

Category :

Surgical Equipment

No. of Pages : 72 Pages


Vermillion, Inc. (VRML) is a pharmaceutical company. It undertakes the discovery, development and commercialization of diagnostic tests to improve patient care by physicians. The company offers diagnostic products with focus on therapeutic areas, such as oncology, cardiology and hematology. It develops and offers diagnostic tests, such as thrombotic thrombocytopenic purpura (TTP) test, peripheral artery disease (PAD) blood test, and ovarian tumor triage test. The company maintains collaborations with various pharmaceutical companies and research institutions, such as University of Texas M. D. Anderson Cancer Center, John Hopkins School of Medicine, Stanford University, University of Kentucky, Rigshospitalet, and Ohio State University Research Foundation. Geographically, it operates through its subsidiaries in Switzerland, Denmark, the UK, Japan, China and Germany. VRML is headquartered in Texas, the US.

The company aims to continue the expansion of its existing portfolio of biomarker related patents in ovarian cancer and other important disease states. This intent can be indicated by its latest patent allowance, which further strengthens the ovarian cancer franchise behind its lead product, OVA1, and also offers creative new options to detect and manage this cancer. It mainly aims to continue its innovative biomarker research to build its platform of proprietary diagnostic tools, that is supported by key patents. The company also aims to maintain its existing partnerships and to enter new collaborative agreements to augment its services. This is indicated from the recent acquisition of Correlogic Systems, Inc.\'s ovarian cancer diagnostics business and recent collaboration agreements signed with Quest Diagnostics for launching OVA1 in India and with Pronto Diagnostics Ltd. for distributing its OVA1 in Israel and the Palestinian territories.

This report is a source for data, analysis and actionable intelligence on the Vermillion, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5
Vermillion, Inc. - Business Description 6
Key Facts 7
Vermillion, Inc. - Major Products and Services 8
Vermillion, Inc. Pipeline Products by Equipment Type 9
Vermillion, Inc. Pipeline Products by Development Stage 11
Vermillion, Inc. Pipeline Products by Therapy Area 13
Vermillion, Inc. Pipeline Products by Trial Phase 15
Vermillion, Inc. Pipeline Products by Milestone Summary 16
Biomarker Assay - Breast Cancer 18
Biomarker Assay - Breast Cancer Product Status 18
Biomarker Assay - Breast Cancer Product Description 18
Biomarker Assay - Breast Cancer Product Patent Details 18
Product Institution Details 21
Diagnostic Assay - Alzheimer\'s Disease 22
Diagnostic Assay - Alzheimer\'s Disease Product Status 22
Diagnostic Assay - Alzheimer\'s Disease Product Description 22
Diagnostic Assay - Alzheimer\'s Disease Product Patent Details 22
Diagnostic Assay - Colorectal Cancer 24
Diagnostic Assay - Colorectal Cancer Product Status 24
Diagnostic Assay - Colorectal Cancer Product Description 24
Diagnostic Assay - Colorectal Cancer Product Milestone 24
Diagnostic Assay - Colorectal Cancer Product Patent Details 25
MammoCheck 35
MammoCheck Product Status 35
MammoCheck Product Description 35
MammoCheck Product Milestone 35
MammoCheck Product Patent Details 36
OVA2 41
OVA2 Product Status 41
OVA2 Product Description 41
OVA2 Product Milestone 41
OVA2 Product Patent Details 42
Product Institution Details 44
Prognostic Test - Ovarian Cancer 45
Prognostic Test - Ovarian Cancer Product Status 45
Prognostic Test - Ovarian Cancer Product Description 45
ProstaCheck 46
ProstaCheck Product Status 46
ProstaCheck Product Description 46
ProstaCheck Product Milestone 46
ProstaCheck Product Patent Details 47
VASCLIR 57
VASCLIR Product Status 57
VASCLIR Product Description 57
VASCLIR Product Milestone 57
VASCLIR Clinical Trial 58
VASCLIR Product Patent Details 58
Vermillion, Inc. - Key Competitors 62
Vermillion, Inc. - Key Employees 63
Vermillion, Inc. - Key Employee Biographies 64
Vermillion, Inc. - Locations And Subsidiaries 65
Head Office 65
Other Locations & Subsidiaries 65
Recent Developments 66
Vermillion, Inc., Recent Developments 66
May 15, 2012: Vermillion Announces Resignation Of Gail S Page As CEO 66
May 15, 2012: Vermillion Reports Q1 2012 Results 66
Apr 30, 2012: Vermillion Resolves Non-Contingent Claims With Bio-Rad 67
Mar 28, 2012: Vermillion Receives Notice Of Allowance For Patent On Methods For Diagnosing Ovarian Cancer 67
Mar 27, 2012: Vermillion Reports Revenue Of $1.9m In 2011 67
Mar 05, 2012: Vermillion Receives Notice Of Allowance For Patent On Platelet Biomarkers Of Angiogenesis 69
Jan 04, 2012: Vermillion Plans To Streamline Organization 69
Nov 09, 2011: Vermillion Reports Q3 2011 Results 70
Nov 03, 2011: Vermillion Receives Notice Of Allowance For Fifth Biomarker Patent Related To PAD 70
Sep 26, 2011: Vermillion Announces Management Changes 71

Appendix 72
Methodology 72
About GlobalData 72
Contact Us 72
Disclaimer 72

List of Table


Vermillion, Inc., Key Facts 1
Vermillion, Inc. Key Pipeline Products by Equipment Type 1
Vermillion, Inc. Key Pipeline Products by Therapy Area 1
Vermillion, Inc. Key Pipeline Products by Development Stage 1
Vermillion, Inc. Key Pipeline Products by Trial Phase 1
Vermillion, Inc., Key Facts 7
Vermillion, Inc., Major Products and Services 8
Vermillion, Inc. Number of Pipeline Products by Equipment Type 9
Vermillion, Inc. Pipeline Products by Equipment Type 10
Vermillion, Inc. Number of Pipeline Products by Development Stage 11
Vermillion, Inc. Pipeline Products by Development Stage 12
Vermillion, Inc. Number of Pipeline Products by Therapy Area 13
Vermillion, Inc. Pipeline Products by Therapy Area 14
Vermillion, Inc. Number of Pipeline Products by Trial Phase 15
Vermillion, Inc. Pipeline Products by Trial Phase 15
Vermillion, Inc. Number of Pipeline Products By Milestone Summary 16
Vermillion, Inc. Pipeline Products by Milestone Summary 17
Biomarker Assay - Breast Cancer - Product Status 18
Biomarker Assay - Breast Cancer - Product Description 18
Biomarker Assay - Breast Cancer - Patent Details 18
Diagnostic Assay - Alzheimer\'s Disease - Product Status 22
Diagnostic Assay - Alzheimer\'s Disease - Product Description 22
Diagnostic Assay - Alzheimer\'s Disease - Patent Details 22
Diagnostic Assay - Colorectal Cancer - Product Status 24
Diagnostic Assay - Colorectal Cancer - Product Description 24
Diagnostic Assay - Colorectal Cancer - Product Milestone 24
Diagnostic Assay - Colorectal Cancer - Patent Details 25
MammoCheck - Product Status 35
MammoCheck - Product Description 35
MammoCheck - Product Milestone 35
MammoCheck - Patent Details 36
OVA2 - Product Status 41
OVA2 - Product Description 41
OVA2 - Product Milestone 41
OVA2 - Patent Details 42
Prognostic Test - Ovarian Cancer - Product Status 45
Prognostic Test - Ovarian Cancer - Product Description 45
ProstaCheck - Product Status 46
ProstaCheck - Product Description 46
ProstaCheck - Product Milestone 46
ProstaCheck - Patent Details 47
VASCLIR - Product Status 57
VASCLIR - Product Description 57
VASCLIR - Product Milestone 57
VASCLIR - Peripheral Artery Disease Diagnostic Test Clinical Study 58
VASCLIR - Patent Details 58
Vermillion, Inc., Key Employees 63
Vermillion, Inc., Key Employee Biographies 64
Vermillion, Inc., Subsidiaries 65

List of Chart


Vermillion, Inc. Pipeline Products by Equipment Type 9
Vermillion, Inc. Pipeline Products by Development Stage 11
Vermillion, Inc. Pipeline Products by Therapy Area 13
Vermillion, Inc. Pipeline Products by Trial Phase 15
Vermillion, Inc. Pipeline Products by Milestone Summary 16

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *